Olema Oncology, Inc. (OLMA) stock forecast and price target
Price $7.56 · data as of November 13, 2026
12-month price target
Average target$35.50
Upside / downside+369.6%
Analysts10
ConsensusStrong buy
Low $13.00Average $35.50High $59.00
Gold marker: average target · white marker: today’s price ($7.56)
Analyst ratings
Strong buy 2Buy 9Hold 1Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-2.56 | −36.8% | $0 |
| Next fiscal year ends December 31, 2027 | $-2.90 | −13.3% | $14M |
| Quarter after ends December 31, 2026 | $-0.70 | −41.0% | $0 |
Consensus of the analysts covering Olema Oncology, updated daily. In the last 30 days 1 estimates were raised and 7 lowered.
Frequently asked questions
What is the Olema Oncology stock price target?
The average 12-month target from 10 analysts is $35.50, 369.6% above the current price of $7.56 Targets range from $13.00 to $59.00.
Is Olema Oncology a buy according to analysts?
The consensus rating is “Strong buy” (2 strong buy, 9 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Olema Oncology expected to earn?
Analysts expect EPS of $-2.56 for the fiscal year ending December 31, 2026 and $-2.90 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.